A large pharma company, operating in the rare disease therapeutic area, faced a critical challenge: identifying and pre-qualifying relevant real-world data sources swiftly and accurately. They sought to create a reliable repository for future real-world evidence needs, including trial optimization, patient pathway analysis, and therapeutic strategy improvement.

The Challenge: Rarity and Specificity

• Complex Landscape: The rarity and complexity of the condition demanded a multiplicity of very specific data sources.

The Solution: IQVIA's Health Data Catalog (IHDC)

• Advanced Search and Filtering: Leveraging IHDC's advanced capabilities, IQVIA identified over 70 relevant data sources across 30+ countries.
• Quality Assurance: Metadata information for these assets was exported from IHDC, benefiting from the strong quality of data and central orchestration.
• Unique Maintenance Process: IHDC's unique maintenance process ensures that data asset information remains accurate and up-to-date.

Results and Implications: Efficiency Amplified

• Swift Identification: In just a few minutes, the client achieved what would typically take days.
• On-Demand Refreshes: The client can generate on-demand refreshes, ensuring data accuracy and relevancy.